NCT05558397 2025-04-04
Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment
Universidade Federal de Alfenas
Phase NA Completed
Clinical Trials
10 trialsNCT05236647 2025-03-06
SIM
University Hospital, Akershus
Phase 3 Completed
NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT01541124 2018-02-08
Morphine as First Drug for Cancer Pain
Federal University of São Paulo
Phase NA Completed
NCT02078089 2017-01-31
Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Indiana University
Phase 1 Terminated
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01946555 2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
NCT01809106 2015-12-24
CERP
Mario Negri Institute for Pharmacological Research
Phase 4 Completed
NCT00916890 2014-01-09
Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 4 Suspended
NCT00125684 2012-01-19
Bioavailability and Effectiveness of Transdermally Administered Morphine
AHS Cancer Control Alberta
Phase 1 Completed